Evidence map›Paper›PMID 40938648›Full record

ArticleJournal of bacteriology2025

A new family of small ArdA proteins reveals antirestriction activity.

A A Utkina, A A Kudryavtseva, O E Melkina, S M Rastorguev, A V Vlasov, K S Pustovoit, I V Manukhov

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. DNA-Mimic Antirestriction Proteins ArdA Could Regulate Gene Expression inInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A A UtkinaMoscow Center for Advanced Studies, Moscow, Russia.
A A KudryavtsevaMoscow Center for Advanced Studies, Moscow, Russia.ORCID 0000-0001-7274-877X
O E MelkinaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.ORCID 0000-0002-7507-4827
S M RastorguevPirogov Russian National Research Medical University, Moscow, Russia.
A V VlasovMoscow Center for Advanced Studies, Moscow, Russia.
K S PustovoitComplex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.
I V ManukhovMoscow Center for Advanced Studies, Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-03-2025-662 project FSMG-2025-0003Ministry of Science and Higher Education of the Russian Federation State Assignment for the Research Center Kurchatov InstituteRussian Science Foundation project 24-74-00024
6 · The paper itself

Abstract

Antirestriction proteins protect mobile genetic elements from the host's restriction-modification (RM) systems. In our study, we identified a new family of small proteins, which we named sArdA. The sArdA proteins are homologous to DNA-mimicking ArdA proteins but differ in size, being approximately one-third the length of full ArdAs. Moreover, the sArdA family contains two subgroups, one of which is structurally similar to the N-terminal end of ArdA, whereas the other one matches the C-terminal end. Both the N-terminal and C-terminal domains of ArdA appear capable of independent expression. Phylogenetic analysis demonstrated that genes encoding these proteins evolved into evolutionarily stable subfamilies, named sArdN and sArdC, respectively. AlphaFold structure prediction of sArdA interaction with RM systems revealed four states of EcoKI, which differ in the angle between its two M-subunits while interacting with different ArdAs or DNA. Interestingly, both sArdN and sArdC triggered the same intermediate closed state of EcoKI, indicating possible new interaction pathways of Ards with RM systems. For phenotypic studies in

Indexed as

Bacterial ProteinsDNA Restriction-Modification EnzymesAmino Acid SequenceEscherichia coliGene Expression Regulation, BacterialPhylogenyBacterial ProteinsDNA Restriction-Modification EnzymesantirestrictionArdAmodificationrestriction

Identifiers

PMID40938648
PMCPMC12548430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.